Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,946
datasets available to search
ShareScore release 0.9.0
Dataset results
5,946 results for “diabetes type 2”
Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes
ClinicalTrials.gov study NCT00859898. IPD Sharing: Not stated. Countries: 6. Publications: 1.
A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R
ClinicalTrials.gov study NCT02079805. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01177813. IPD Sharing: Not stated. Countries: 9. Publications: 4.
Effects of Rosiglitazone on Renal Hemodynamics and Proteinuria of Type 2 Diabetic Patients With Renal Insufficiency Due to Overt Diabetic Nephropathy
ClinicalTrials.gov study NCT00324675. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
ClinicalTrials.gov study NCT00082407. IPD Sharing: Not stated. Countries: 12. Publications: 3.
A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD)
ClinicalTrials.gov study NCT01621178. IPD Sharing: YES. Countries: 9. Publications: 2.
Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes and Moderate Renal Impairment
ClinicalTrials.gov study NCT02827708. IPD Sharing: YES. Countries: 8. Publications: 7.
A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetes
ClinicalTrials.gov study NCT04109547. IPD Sharing: YES. Countries: 6. Publications: 1.
A Study of LY3437943 in Participants With Type 2 Diabetes
ClinicalTrials.gov study NCT04867785. IPD Sharing: YES. Countries: 2. Publications: 2.
A Study of LY2189102 in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT00942188. IPD Sharing: YES. Countries: 1. Publications: 1.
GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
ClinicalTrials.gov study NCT00712673. IPD Sharing: Not stated. Countries: 16. Publications: 4.
Comparing the Efficacy and Safety of NN1250 Once Daily When Titrated Using 2 Different Algorithms in Insulin naïve Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01326026. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT01167881. IPD Sharing: Not stated. Countries: 23. Publications: 5.
Trial to Evaluate the Efficacy and Safety of Dapagliflozin in Japanese Type 2 Diabetes Mellitus Patients
ClinicalTrials.gov study NCT00972244. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Can Vitamin D3 Improve Cognitive Function in Individuals With Type 2 Diabetes? (THINK-D)
ClinicalTrials.gov study NCT02416193. IPD Sharing: NO. Countries: 1. Publications: 40.
Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin)
ClinicalTrials.gov study NCT02354235. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
ClinicalTrials.gov study NCT03882970. IPD Sharing: YES. Countries: 13. Publications: 9.
Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to SGLT-2i in Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT03086330. IPD Sharing: YES. Countries: 7. Publications: 1.
A Study for Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT00804986. IPD Sharing: Not stated. Countries: 11. Publications: 1.
A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom T
ClinicalTrials.gov study NCT00740051. IPD Sharing: Not stated. Countries: 7. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.